Narrative Review of Artificial Pancreas Technologies
Kibibi Muthoni L.
Faculty of Science and Technology Kampala International University Uganda
ABSTRACT
The artificial pancreas (AP) represents a transformative approach in the management of type 1 diabetes mellitus, aiming to automate insulin delivery and maintain glucose homeostasis. This narrative review synthesizes current knowledge on AP technologies, including hybrid and fully closed-loop systems, sensor modalities, actuation mechanisms, control algorithms, and clinical outcomes. Historical development from early intravenous systems to modern wearable devices highlights the evolution of closed-loop insulin delivery and bihormonal approaches. Advances in continuous glucose monitoring, predictive algorithms, and personalized control strategies have demonstrated significant improvements in glycemic control, reduction of hypoglycemic events, and enhanced patient quality of life across pediatric, adolescent, and adult populations. Despite clinical successes, challenges persist in sensor accuracy, real-world usability, regulatory approval, and integration of multi-hormonal or multi-drug approaches. Ethical considerations, patient adherence, and methodological limitations in clinical evaluations further underscore the need for ongoing research. Future directions emphasize standardization of key performance metrics, enhanced interoperability, and expansion of artificial pancreas accessibility to diverse populations. Overall, AP technologies offer a promising pathway toward replicating physiological insulin regulation and improving outcomes for individuals with type 1 diabetes.
Keywords: Artificial pancreas, Closed-loop insulin delivery, Type 1 diabetes mellitus, Continuous glucose monitoring, and Hybrid and bihormonal systems
CITE AS: Kibibi Muthoni L. (2026). Narrative Review of Artificial Pancreas Technologies. IDOSR JOURNAL OF APPLIED SCIENCES 11(1):44-50. https://doi.org/10.59298/IDOSRJAS/2026/1114450
